JP2016508036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508036A5 JP2016508036A5 JP2015550089A JP2015550089A JP2016508036A5 JP 2016508036 A5 JP2016508036 A5 JP 2016508036A5 JP 2015550089 A JP2015550089 A JP 2015550089A JP 2015550089 A JP2015550089 A JP 2015550089A JP 2016508036 A5 JP2016508036 A5 JP 2016508036A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fragment
- variant
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12425208.1A EP2749569A1 (en) | 2012-12-28 | 2012-12-28 | Variant of BPIFB4 protein |
| EP12425208.1 | 2012-12-28 | ||
| PCT/EP2013/078076 WO2014102343A1 (en) | 2012-12-28 | 2013-12-27 | Variant of bpifb4 protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508036A JP2016508036A (ja) | 2016-03-17 |
| JP2016508036A5 true JP2016508036A5 (https=) | 2017-02-09 |
| JP6461810B2 JP6461810B2 (ja) | 2019-01-30 |
Family
ID=47715813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015550089A Active JP6461810B2 (ja) | 2012-12-28 | 2013-12-27 | Ｂｐｉｆｂ４タンパク質の変異体 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20150344536A1 (https=) |
| EP (4) | EP2749569A1 (https=) |
| JP (1) | JP6461810B2 (https=) |
| CN (1) | CN104955836B (https=) |
| AU (1) | AU2013369292B2 (https=) |
| CA (1) | CA2896166A1 (https=) |
| ES (2) | ES2731126T3 (https=) |
| WO (1) | WO2014102343A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2749569A1 (en) | 2012-12-28 | 2014-07-02 | Annibale Alessandro Puca | Variant of BPIFB4 protein |
| CN104558144B (zh) * | 2014-12-30 | 2017-08-08 | 深圳市第二人民医院 | 鼠Bpifb5突变体、蛋白及其应用 |
| EP3668891B1 (en) | 2017-08-16 | 2023-07-26 | Lgv1 S.R.L. | Vtft isoform of a bpifb4 protein for use in neuronal deseases and injuries |
| EP4434534A1 (en) | 2023-03-22 | 2024-09-25 | ADvantage Therapeutics, Inc. | Klotho mrna |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL87737A (en) * | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| US6391311B1 (en) * | 1998-03-17 | 2002-05-21 | Genentech, Inc. | Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1 |
| US6924357B2 (en) * | 2000-04-18 | 2005-08-02 | Merck Patent Gmbh | Lipid binding protein 4 |
| JP2004532006A (ja) | 2001-02-08 | 2004-10-21 | インサイト・ゲノミックス・インコーポレイテッド | 細胞内シグナル伝達分子 |
| AU2002359284A1 (en) | 2001-12-17 | 2003-06-30 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| CN1856576B (zh) | 2003-09-30 | 2011-05-04 | 宾夕法尼亚州立大学托管会 | 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用 |
| WO2006022619A2 (en) * | 2004-07-22 | 2006-03-02 | Sequenom, Inc. | Methods for identifying risk of type ii diabetes and treatments thereof |
| CA2653600A1 (en) | 2006-05-31 | 2007-12-06 | The Children's Hospital Of Philadelphia | Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| WO2008073915A2 (en) | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Micrornas differentially expressed in leukemia and uses thereof |
| EP2019143A1 (en) | 2007-07-23 | 2009-01-28 | Genethon | CNS gene delivery using peripheral administration of AAV vectors |
| WO2010071832A1 (en) | 2008-12-19 | 2010-06-24 | Nationwide Children's Hospital | Delivery of polynucleotides across the blood brain barrier using recombinant aav9 |
| JP2011231022A (ja) * | 2010-04-23 | 2011-11-17 | Ajinomoto Co Inc | イミダゾロン誘導体 |
| DK2675902T3 (da) | 2011-02-17 | 2019-06-03 | Univ Pennsylvania | Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel |
| AU2013243948A1 (en) | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins associated with human disease |
| EP2749569A1 (en) * | 2012-12-28 | 2014-07-02 | Annibale Alessandro Puca | Variant of BPIFB4 protein |
-
2012
- 2012-12-28 EP EP12425208.1A patent/EP2749569A1/en not_active Withdrawn
-
2013
- 2013-12-27 EP EP13814575.0A patent/EP2938629B1/en active Active
- 2013-12-27 EP EP19167663.4A patent/EP3560952B9/en active Active
- 2013-12-27 EP EP23177551.1A patent/EP4253405A3/en active Pending
- 2013-12-27 AU AU2013369292A patent/AU2013369292B2/en active Active
- 2013-12-27 ES ES13814575T patent/ES2731126T3/es active Active
- 2013-12-27 CA CA2896166A patent/CA2896166A1/en active Pending
- 2013-12-27 US US14/655,651 patent/US20150344536A1/en not_active Abandoned
- 2013-12-27 WO PCT/EP2013/078076 patent/WO2014102343A1/en not_active Ceased
- 2013-12-27 JP JP2015550089A patent/JP6461810B2/ja active Active
- 2013-12-27 CN CN201380068475.8A patent/CN104955836B/zh active Active
- 2013-12-27 ES ES19167663T patent/ES2951691T3/es active Active
-
2019
- 2019-07-15 US US16/511,051 patent/US11208447B2/en active Active
-
2021
- 2021-11-12 US US17/525,531 patent/US11891421B2/en active Active
-
2023
- 2023-12-19 US US18/545,302 patent/US12486308B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230210887A1 (en) | Nucleic acid molecules for reduction of papd5 or papd7 mrna for treating hepatitis b infection | |
| EP2281040B1 (en) | Lyophilized dna formulations for enhanced expression of plasmid dna | |
| JP2014526441A5 (https=) | ||
| JP2016508036A5 (https=) | ||
| JP2016518325A5 (https=) | ||
| US20240271139A1 (en) | Engineered Guide RNAs and Polynucleotides | |
| JP2006502702A5 (https=) | ||
| CN116785309A (zh) | 环状rna在制备用于预防和/或治疗缺血性卒中药物中的应用 | |
| US11466276B2 (en) | Stem-loop compositions and methods for inhibiting factor D | |
| JP6461810B2 (ja) | Ｂｐｉｆｂ４タンパク質の変異体 | |
| CN104288781B (zh) | miR‑329在制备预防和/或治疗缺血性眼部疾病的药物中的应用 | |
| CN105079780B (zh) | 一种特异结合trb3的多肽在治疗腹主动脉瘤中的应用 | |
| CN104288764B (zh) | Cd146作为预防和/或治疗缺血性眼部疾病的药物靶点的应用 | |
| CN113846098B (zh) | 一种小rna及其在心血管疾病治疗中的用途 | |
| US12540330B2 (en) | Stem-loop compositions and methods for inhibiting vascular endothelial growth factor | |
| CN116355901A (zh) | 一种靶向人DMD位点的sgRNA及其应用 | |
| EP4301863A1 (en) | Compositions and methods for the treatment of hemophilia | |
| JPWO2009013794A1 (ja) | インスリン分泌誘導剤及び膵臓β細胞増加促進剤 | |
| JP2023509067A (ja) | コドン最適化ＴＩＦ１γポリヌクレオチドを含む組換えベクターおよびその用途 | |
| WO2003091271A1 (en) | Alternatively spliced nucleic acid molecules | |
| CN103601808A (zh) | 新型钠肽、制备方法及其在制备基因工程药物中的应用 | |
| JP2007209214A (ja) | インスリン分泌誘導剤、インスリン分泌誘導組成物及びその製造方法、遺伝子治療用ウイルスベクター | |
| JPWO2018088464A1 (ja) | 脳梗塞の治療薬 | |
| Seneviratne et al. | 181 M1 MACROPHAGES AND IRF5 EXACERBATE ATHEROSCLEROTIC DISEASE | |
| CN120695213A (zh) | 用于治疗肺气肿的mRNA组合产品及其应用 |